IgMAT

IgMAT annotates immunoglobulin (antibody) sequences from high-throughput sequencing datasets to map framework (FR) and complementarity-determining regions (CDRs) across diverse species.


Key Features:

  • Species-Agnostic Annotation: Annotates antibody sequences from diverse species and accepts user-defined datasets to represent species-specific structural characteristics.
  • Reduced Amino Acid Alphabet and HMM Alignments: Uses a reduced amino acid alphabet and combines multiple Hidden Markov Model (HMM) alignments into a single consensus model to improve annotation accuracy across species.
  • Customizability: Allows users to add custom antibody sequence datasets for annotation of non-standard or underrepresented species.
  • Output Formats: Generates output formats including BED files that contain coordinates for Framework (FR) and Complementarity-Determining Regions (CDR).

Scientific Applications:

  • Immunogenetics: Supports immunogenetics studies requiring precise annotation of antibody regions.
  • Immune Repertoire Profiling: Enables mapping of changes in polyclonal immune repertoires from high-throughput sequencing, including responses to disease and vaccination.
  • Cross-Species Antibody Research: Facilitates analysis of antibody repertoires from non-model species by allowing custom datasets and species-agnostic annotation.

Methodology:

Implemented as a Python module that applies a reduced amino acid alphabet and integrates multiple HMM alignments into a consensus model for sequence annotation.

Topics

Details

License:
GPL-3.0
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python
Added:
2/24/2022
Last Updated:
2/24/2022

Operations

Data Inputs & Outputs

Sequence alignment conversion

Outputs

    Publications

    Dorey-Robinson D, Maccari G, Borne R, Hammond JA. IgMAT: immunoglobulin sequence multi-species annotation tool for any species including those with incomplete antibody annotation or unusual characteristics. Unknown Journal. 2021. doi:10.1101/2021.09.22.461368.